Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NSC vs GSK✓SelectedUSD · GSKNSC vs GSK performance historyLatest closeAs of+0.42%11/16
Stock and ETF performance explorer

NSC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+290.2%
GSK return
+107.3%
Excess return
+182.9%
Maximum drawdown
-44.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.4%-0.1%+0.5%+0.5%
7D+1.1%-1.3%+2.4%+1.5%
30D+1.1%+2.7%-1.6%+0.2%
3M-1.1%+2.7%-3.8%-2.3%
6M+5.1%+3.3%+1.7%+3.4%
YTD+16.0%+6.5%+9.5%+12.3%
1Y+17.9%+10.7%+7.3%+12.7%
3Y+67.9%+64.4%+3.5%+34.8%
5Y+33.5%+46.7%-13.2%+9.6%
10Y+290.2%+109.4%+180.9%+189.0%
All+290.2%+107.3%+182.9%+189.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling